AMA to CMS: Critical Changes Needed Before Moving to Meaningful Use Stage 3
The American Medical Association today called on the Centers for Medicare and Medicaid Services to address the challenges physicians are facing with the Meaningful Use program.
PRESS RELEASE
Chicago — The American Medical Association (AMA) today called on the Centers for Medicare and Medicaid Services (CMS) to address the challenges physicians are facing with the Meaningful Use program before moving on to the next stage. In a
from AMA Chief Executive Officer and EVP James L. Madara, MD, the AMA recommended the program focus on patient safety, privacy and security, interoperability and how we can promote rather than hinder innovation.
“As we’ve said many times, the Meaningful Use program is not meaningful in its current form and is not helping physicians use electronic health records in a way that facilitates the best care coordination, increases efficiency or improves the quality of care for patients,” said AMA President-elect Steven J. Stack, MD. “We cannot ignore the current problems and barriers that exist with the program. The recommendations we provided address the significant challenges facing physicians, patients and vendors, and, if adopted, will lead to higher quality, cost effective care and increased innovation.”
Despite the fact that more than 80 percent of physicians are now using electronic health records (EHRs), less than 10 percent of eligible professionals were able to attest for Stage 2 Meaningful Use in 2014. The AMA recently
The draft Stage 3 regulations were also drafted before CMS had the opportunity to assess the structure, requirements and impact of the new Merit-Based Incentive Payment Systems (MIPS). The MIPS program, which was created by the recent
Additionally, as evidenced in a recent Office of the National Coordinator for Health IT (ONC)
The AMA is working to address interoperability challenges as a founding member of the
and
, which aim to resolve interoperability issues such as patient matching and information exchange rules.
Should the administration decides to proceed with moving to Stage 3 in 2018, the AMA has proposed a number of recommendations for improvements including:
- Making 2017 a transitional year to alleviate many of the concerns both vendors and providers have regarding program updates, system changes and reengineering workflows
- Implementing a reporting period that is less than a full year, to accommodate many unforeseen system disruptions that can occur outside the physician’s control
- Consulting physicians and vendors before removing or adding measures
- Heavily modifying the proposed objectives to align with the needs of medical specialists
- Allowing quality measures reported to clinical registries to count for Meaningful Use quality reporting requirements
The AMA also sent a comment letter to CMS and ONC today regarding the proposed 2015 Edition Health Information Technology (Health IT) Certification Criteria. Among other things, the letter highlighted the AMA’s concern for the aggressive short timeframe that health IT vendors will have to produce highly-usable, interoperable, and safe technologies prior to 2018. For more information on that letter, please click
.
Our collaboration with the administration, policymakers, vendors, patient groups and other stakeholders to improve the Meaningful Use and EHR Certification programs is part of our ongoing
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Related Articles
- Effectively Managing Immunizations in the Long-Term Care Setting
September 18th 2025
- Creating a Culture of Quality in Fast-Melt Tablet Development
September 18th 2025
- Advise Patients About Self-Care Measures to Treat Mild to Moderate GI Issues
September 18th 2025